These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 18844215)

  • 1. Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies.
    Alex P; Gucek M; Li X
    Inflamm Bowel Dis; 2009 Apr; 15(4):616-29. PubMed ID: 18844215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advantages in the application of proteomics in inflammatory bowel disease.
    Vaiopoulou A; Gazouli M; Theodoropoulos G; Zografos G
    Dig Dis Sci; 2012 Nov; 57(11):2755-64. PubMed ID: 22740064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.
    Bennike T; Birkelund S; Stensballe A; Andersen V
    World J Gastroenterol; 2014 Mar; 20(12):3231-44. PubMed ID: 24696607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics: addressing the challenges of multiple myeloma.
    Ge F; Tao S; Bi L; Zhang Z; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2011 Feb; 43(2):89-95. PubMed ID: 21212069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: where are we now in the era of the next generation proteomics?
    Park JM; Han NY; Han YM; Chung MK; Lee HK; Ko KH; Kim EH; Hahm KB
    World J Gastroenterol; 2014 Oct; 20(37):13466-2476. PubMed ID: 25309077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.
    Titz B; Gadaleta RM; Lo Sasso G; Elamin A; Ekroos K; Ivanov NV; Peitsch MC; Hoeng J
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current application of proteomics in biomarker discovery for inflammatory bowel disease.
    Chan PP; Wasinger VC; Leong RW
    World J Gastrointest Pathophysiol; 2016 Feb; 7(1):27-37. PubMed ID: 26909226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic insights on the metabolism in inflammatory bowel disease.
    Pisani LF; Moriggi M; Gelfi C; Vecchi M; Pastorelli L
    World J Gastroenterol; 2020 Feb; 26(7):696-705. PubMed ID: 32116417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput omics technologies in inflammatory bowel disease.
    Xu C; Shao J
    Clin Chim Acta; 2024 Mar; 555():117828. PubMed ID: 38355001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel Disease.
    Baldan-Martin M; Chaparro M; Gisbert JP
    Inflamm Bowel Dis; 2021 Jul; 27(8):1184-1200. PubMed ID: 33529308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review.
    Gisbert JP; Chaparro M
    J Crohns Colitis; 2019 Mar; 13(3):374-384. PubMed ID: 30307487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New proteomic approaches for biomarker discovery in inflammatory bowel disease.
    Roda G; Caponi A; Benevento M; Nanni P; Mezzanotte L; Belluzzi A; Mayer L; Roda A
    Inflamm Bowel Dis; 2010 Jul; 16(7):1239-46. PubMed ID: 20127998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling.
    Meuwis MA; Fillet M; Geurts P; de Seny D; Lutteri L; Chapelle JP; Bours V; Wehenkel L; Belaiche J; Malaise M; Louis E; Merville MP
    Biochem Pharmacol; 2007 May; 73(9):1422-33. PubMed ID: 17258689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic biomarkers in inflammatory bowel disease].
    Kanmura S; Sakiyama T; Uto H; Tsubouchi H
    Nihon Rinsho; 2012 May; 70(5):790-5. PubMed ID: 22620002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics technologies for the global identification and quantification of proteins.
    Brewis IA; Brennan P
    Adv Protein Chem Struct Biol; 2010; 80():1-44. PubMed ID: 21109216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiopathogenesis of inflammatory bowel disease: today and tomorrow.
    de Souza HSP
    Curr Opin Gastroenterol; 2017 Jul; 33(4):222-229. PubMed ID: 28402995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.
    Mourad FH; Yau Y; Wasinger VC; Leong RW
    Dig Dis Sci; 2017 Sep; 62(9):2266-2276. PubMed ID: 28717845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis.
    Baldan-Martin M; Chaparro M; Gisbert JP
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.
    Kalla R; Adams AT; Bergemalm D; Vatn S; Kennedy NA; Ricanek P; Lindstrom J; Ocklind A; Hjelm F; Ventham NT; Ho GT; Petren C; Repsilber D; Söderholm J; Pierik M; D'Amato M; Gomollón F; Olbjorn C; Jahnsen J; Vatn MH; Halfvarson J; Satsangi J
    J Crohns Colitis; 2021 May; 15(5):699-708. PubMed ID: 33201212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Metaproteomics and Activity-Based Probe Enrichment Reveals Significant Alterations in Protein Expression from a Mouse Model of Inflammatory Bowel Disease.
    Mayers MD; Moon C; Stupp GS; Su AI; Wolan DW
    J Proteome Res; 2017 Feb; 16(2):1014-1026. PubMed ID: 28052195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.